Work

Rituximab pre-conditioning in a phase I study of CARv3-TEAM-E for recurrent glioblastoma (GBM): The INCIPIENT trial.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.2059

Authors: Bryan D. Choi, Elizabeth R. Gerstner, William T. Curry, Deborah Anne Forst, Alona Muzikansky, Estelle Emmanuel-Alejandro, Gabrielle Furman, Daniella Oi, Danielle Bernier, Lu Huang, Trisha Berger, Sarah Nikiforow, Matthew J. Frigault, Kathleen Gallagher, Marcela Valderrama Maus

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162562940

Cites:

Cited by:

Related to: